SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14C - Revised information statement materials, definitive:
SEC Accession No. 0001654954-20-003722
Filing Date
2020-04-02
Accepted
2020-04-02 15:32:33
Documents
1
Effectiveness Date
2020-04-02

Document Format Files

Seq Description Document Type Size
1 DEFR14C sbfm_defr14c.htm DEFR14C 99422
  Complete submission text file 0001654954-20-003722.txt   100715
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEFR14C | Act: 34 | File No.: 000-52898 | Film No.: 20768712
SIC: 8731 Services-Commercial Physical & Biological Research